Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3.5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.Peer reviewe

Effect of five Alive&#174 fruit juice on the dissolution and absorption profiles of ciprofloxacin

No Abstract. Nigerian Quarterly Journal of Hospital Medicine Vol. 17 (1) 2007: pp. 53-5

Micronutrient deficiencies in African soils and the human nutritional nexus: opportunities with staple crops

A synthesis of available agronomic datasets and peer-reviewed scientific literature was conducted to: (1) assess the status of micronutrients in sub-Saharan Africa (SSA) arable soils, (2) improve the understanding of the relations between soil quality/management and crop nutritional quality and (3) evaluate the potential profitability of application of secondary and micronutrients to key food crops in SSA, namely maize (Zea mays L.), beans (Phaseolus spp. and Vicia faba L.), wheat (Triticum aestivum L.) and rice (Oryza sativa L.). We found that there is evidence of widespread but varying micronutrient deficiencies in SSA arable soils and that simultaneous deficiencies of multiple elements (co-occurrence) are prevalent. Zinc (Zn) predominates the list of micronutrients that are deficient in SSA arable soils. Boron (B), iron (Fe), molybdenum (Mo) and copper (Cu) deficiencies are also common. Micronutrient fertilization/agronomic biofortification increases micronutrient concentrations in edible plant organs, and it was profitable to apply fertilizers containing micronutrient elements in 60-80% of the cases. However, both the plant nutritional quality and profit had large variations. Possible causes of this variation may be differences in crop species and cultivars, fertilizer type and application methods, climate and initial soil conditions, and soil chemistry effects on nutrient availability for crop uptake. Therefore, micronutrient use efficiency can be improved by adapting the rates and types of fertilizers to site-specific soil and management conditions. To make region-wide nutritional changes using agronomic biofortification, major policy interventions are needed

Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers